530163 KERALAYUR

Kerala Ayurveda Share Price

 

 

Start SIP in KERALAYUR

Start SIP

Performance

  • Low
  • ₹234
  • High
  • ₹249
  • 52 Week Low
  • ₹220
  • 52 Week High
  • ₹625
  • Open Price₹249
  • Previous Close₹247
  • Volume13,609
  • 50 DMA₹298.46
  • 100 DMA₹342.68
  • 200 DMA₹374.85

Investment Returns

  • Over 1 Month -23.02%
  • Over 3 Month -37.14%
  • Over 6 Month -52.23%
  • Over 1 Year -37.49%

Smart Investing Starts Here Start SIP with Kerala Ayurveda for Steady Growth!

Invest Now

Kerala Ayurveda Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -12.7
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 289
  • P/B Ratio
  • 53.2
  • Average True Range
  • 16.89
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -18.96
  • RSI
  • 35.61
  • MFI
  • 44.9

Kerala Ayurveda Financials

Kerala Ayurveda Technicals

EMA & SMA

Current Price
₹240.00
-7.2 (-2.91%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹262.68
  • 50 Day
  • ₹298.46
  • 100 Day
  • ₹342.68
  • 200 Day
  • ₹374.85

Resistance and Support

250.05 Pivot Speed
  • R3 271.05
  • R2 265.00
  • R1 256.10
  • S1 241.15
  • S2 235.10
  • S3 226.20

Kerala Ayurveda Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results & Preferential issue
2025-11-14 Quarterly Results
2025-07-18 Quarterly Results
2025-05-26 Audited Results
2025-02-14 Quarterly Results

Kerala Ayurveda F&O

Kerala Ayurveda Shareholding Pattern

33.14%
0.02%
0.22%
0.01%
44.42%
22.19%

Kerala Ayurveda FAQs

Kerala Ayurveda share price is ₹240 As on 12 February, 2026 | 13:01

The Market Cap of Kerala Ayurveda is ₹288.8 Cr As on 12 February, 2026 | 13:01

The P/E ratio of Kerala Ayurveda is -12.7 As on 12 February, 2026 | 13:01

The PB ratio of Kerala Ayurveda is 53.2 As on 12 February, 2026 | 13:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23